Here's why Takeda could pay MacroGenics up to $1.6B for four molecules that don't yet exist
October 03, 2014 at 14:49 PM EDT
MacroGenics Inc. this week announced its sixth collaboration surrounding its core platform, a pact with Takeda Pharmaceutical Co...
